ambenonium (Mytelase)

Tradename: Mytelase. (ambenonium chloride) Indications: treatment of myasthenia gravis Dosage: 5-25 mg PO TID-QID Tabs: 10 mg Adverse effects: 1) common (> 10%) - diarrhea - increased sweating - increased lacrimation - nausea - stomach cramps 2) less common (1-10%) - urge to urinate, increased bronchial secretions, miosis 3) uncommon (< 1%) - thrombophlebitis, bradycardia, AV-block, seizures, headache, dysphoria, drowsiness, muscle spasms, diplopia, laryngospasm, respiratory paralysis, hypersensitivity, hyper-reactive cholinergic responses, weakness

Interactions

drug interactions drug adverse effects of cholinesterase inhibitors

General

cholinesterase inhibitor neurologic agent

References

Kaiser Permanente Northern California Regional Drug Formulary, 1998